PetCaseFinder

Peer-reviewed veterinary case report

Genetic variants linked to mitral valve disease severity in Cavalier

By Mead, Sophie E et al.·Published in Genes·2022·Faculty of Science, Australia·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.

Species:
dog

Plain-English summary

A group of Cavalier King Charles Spaniels with myxomatous mitral valve disease (MMVD) were studied to see how genetic factors affected the severity of their heart condition. The research found that dogs with certain protective genetic variants had smaller heart measurements, indicating a lower risk of severe MMVD compared to those without these variants. This suggests that even though many CKCSs carry risk genes for MMVD, some dogs have protective genes that could help reduce the severity of the disease. Understanding these genetic factors could lead to better management and treatment options for affected dogs.

People also search for: Cavalier King Charles Spaniel heart disease · myxomatous mitral valve disease treatment · CKCS genetic testing for heart problems

Abstract

The most common cardiovascular disease in domestic dogs is myxomatous mitral valve disease (MMVD), accounting for 75% of all cardiac disease. An increase in age is generally associated with increased incidence of the disease, but Cavalier King Charles Spaniels (CKCS) exhibit an unusually high prevalence of early-onset MMVD, and thus, potentially greater cardiac morbidity and mortality compared to other breeds. Previous research has suggested that selected candidate risk alleles for MMVD are fixed in CKCSs, including six locations within the() gene on CFA2. The current study analysed genotypes of 180 Australian CKCSs at the identified risk loci. Of these, 178 were phenotyped for severity of disease by echocardiographic measurements of left atrium to aortic root ratio (LA:Ao) and weight normalised left ventricular end diastolic diameter (LVIDdN). Genotyping array markers correctly predicted the genotype at the risk-variant loci in the CKCS population, and the,andvariants were observed to be in perfect linkage disequilibrium in this cohort. The CKCS cohort included 6/178 dogs being heterozygous for the protective/wild-type alleles at the NEBL locus. The mean LA:Ao and LVIDdN scores of these dogs heterozygous atvariants were significantly smaller, and with significantly lower variance compared to age-matched CKCSs that were homozygous for risk alleles. The lower cardiac measurements in the heterozygous dogs indicate a significantly reduced risk of severe MMVD disease. Our analysis suggests that despite relative fixation of the NEBL risk alleles, healthy reference alleles atexist in low frequency in the CKCS breed and can be used to reduce MMVD severity and mortality.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/36553559/